Neuralstem Inc.

Neuralstem Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.35
Market Cap
$6.26 M
Shares Outstanding
20.01 M
Public Float
17.89 M

Profile

Address
20271 Goldenrod Lane
Germantown Maryland 20876
United States
Employees -
Website http://www.neuralstem.com
Updated 07/08/2019
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I.

Financials

View All

William Clyde Oldaker
Chairman
Xi Chen
Director